Takara Bio Inc.
- UEI
- N562J68XWFB3
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Entity structure
- Other
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cgmp grade FN CH-296 retronectin 2.5MG vials. | National Cancer Institute | $12,500 | |
| Clinical grade retronectin | National Cancer Institute | $12,500 | |
| Takara BIO INC.:1178551 [12-010954] | Office of the Chief Operating Officer | $15,000 | |
| GMP grade CH-296 (with certificate)lot ZLE028 | NIAID DEA OA Acquisitions | $3,750 | |
| GMP grade CH-296 retronectin units: vial catalog#: FN-CH-296 | National Cancer Institute | $12,500 |
Quick answers
What is Takara Bio Inc.'s UEI?
Takara Bio Inc.'s Unique Entity ID (UEI) in SAM.gov is N562J68XWFB3.
Is Takara Bio Inc. registered in SAM.gov?
Takara Bio Inc.'s SAM.gov registration expired on March 15, 2013.
What is Takara Bio Inc.'s most recent federal award?
Takara Bio Inc.'s most recent federal contract award is Cgmp grade FN CH-296 retronectin 2.5MG vials (HHSN261201300118P), from National Cancer Institute, on March 15, 2013.
On GovTribe
See Takara Bio Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors